Gastroenterology News

The CDC issued a warning Thursday not to eat pre-cut cantaloupe if the brand of the fruit is not known, the latest development in a growing outbreak of Salmonella infections that has sickened more than 100 people, killing two.

As baby boomers age into their 70s and 80s, it is estimated that more than $84 trillion will pass down through inheritances to millennial and Gen X heirs before 2045.

In the latest installment of Healio’s diversity, equity and inclusion series with ASGE, Elizabeth Paine, MD, outlines how having clear and thorough parental leave policies promotes inclusivity and job retention in gastroenterology.

Patients with high-risk T1 rectal cancer were at greater risk for recurrence after surgical resection than those with colon cancer, although no significant differences were reported after endoscopic local resection, according to research.

BOSTON — Researchers found “significant gaps” in follow-up testing and treatment among a cohort of pregnant individuals in Canada with a diagnosis of hepatitis C virus infection, according to data presented at The Liver Meeting.

BOSTON — Pegozafermin improved fibrosis and other key noninvasive tests at 24 weeks in patients with metabolic dysfunction-associated steatohepatitis-related cirrhosis, according to data presented at The Liver Meeting.

A combination of vedolizumab, adalimumab and methotrexate resulted in endoscopic remission at week 26 in more than a third of patients with Crohn’s disease, according to data in Clinical Gastroenterology and Hepatology.

BOSTON — A treatment trial that recruited individuals chronically infected with hepatitis C virus and provided no-cost medical care helped reduce the proportion of viremic individuals in a rural Appalachian county, data showed.

BOSTON — Treatment with sofosbuvir-based direct-acting antivirals demonstrated durable sustained virologic response up to 5 years among pediatric patients with hepatitis C virus, according to findings presented at The Liver Meeting.

Five obesity advocacy organization have issued a joint statement asking the FDA to mandate that all drug approval trials include people with obesity.